Nuts health claim OK’ed
This article was originally published in The Tan Sheet
FDA affirms first qualified health claim under "Interim Evidence-Based Ranking System for Scientific Data" guidance published in July 11 Federal Register (1"The Tan Sheet" July 14, 2003, p. 3). The claim will allow manufacturers of peanuts, almonds, walnuts and other nuts to say that "scientific evidence suggests but does not prove" that eating 1.5 oz in conjunction with a diet low in saturated fat and cholesterol "may" reduce the risk of developing heart disease...
You may also be interested in...
FDA will rank qualified health claims for use on dietary supplement and food products based on an evaluation of the scientific evidence that supports them, according to guidelines announced July 10
In this week's podcast edition of Five Must-Know Things: a preview of the CTAD Alzheimer’s meeting; US myeloma drug withdrawal puts pressure on GSK; UniQure/CSL's gene therapy sets new US price record; new leadership at Teva; and Merck’s Frazier cautions against profit maximization.
Attention must be paid when withdrawal is for NDA approved in 1948 for brand synonymous with nonprescription pain relief, Bufferin. Even when FDA’s decision amounts to NDA database recordkeeping, withdrawal of application demands notice in US OTC space.